Literature DB >> 19064561

Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.

Hui-Lee Wong1, Ruth M Pfeiffer, Thomas R Fears, Roel Vermeulen, Shaoquan Ji, Charles S Rabkin.   

Abstract

RATIONALE: Cytokines are humoral regulatory molecules that act together in immunologic pathways underlying pathogenesis. Grossly elevated blood levels characterize certain diseases; variations within physiologic ranges could also have significance. We therefore evaluated the performance characteristics of a multiplex cytokine immunoassay.
METHODS: We used a fluorescent bead-based (Luminex) immunoassay kit to simultaneously measure interleukin (IL) 1beta, IL2, IL4, IL5, IL6, IL7, IL8, IL10, IL12p70, IL13, IFNgamma, granulocyte colony-stimulating factor, and tumor necrosis factor-alpha. We tested identical aliquots of serum from 38 asymptomatic individuals on three different days and matched sets of serum, heparinized plasma, and acid citrate dextrose plasma from an additional 38 healthy donors expected to have low cytokine concentrations. We applied multiple imputation to calculate unbiased reproducibility estimates for measurements below the limits of detection. Correlations among the cytokines were assessed by Spearman rank order coefficients and principal components analyses.
RESULTS: Of the 13 cytokines, 3 were undetectable (IL1beta, IL2, IL5) in more than half of the serum samples. Coefficients of variation for replicate serum measurements ranged from 18% to 44%, with intraclass correlation coefficients ranging from 55% to 98%. Only IL4, IL6, and IL8 had statistically significant correlations (Spearman rho, 0.42-0.94) between serum and acid citrate dextrose or heparin plasma levels.
CONCLUSIONS: Interindividual differences outweigh substantial laboratory variation for these assays, yielding high intraclass correlation coefficients despite unimpressive coefficients of variation. Plasma measurements generally are not reflective of serum levels and hence are not interchangeable. With their small volume, low cost per test, and multiplex capacity, Luminex-based cytokine assays have potential utility for epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064561     DOI: 10.1158/1055-9965.EPI-08-0311

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  70 in total

1.  Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.

Authors:  Mark P Purdue; Qing Lan; Rachel Bagni; William G Hocking; Dalsu Baris; Douglas J Reding; Nathaniel Rothman
Journal:  Cancer Res       Date:  2011-06-01       Impact factor: 12.701

2.  Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled Trial.

Authors:  Catherine Duggan; Jean de Dieu Tapsoba; Caitlin Mason; Ikuyo Imayama; Larissa Korde; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-23

3.  Factors associated with inflammation markers, a cross-sectional analysis.

Authors:  Tess V Clendenen; Karen L Koenig; Alan A Arslan; Annekatrin Lukanova; Franco Berrino; Yian Gu; Goran Hallmans; Annika Idahl; Vittorio Krogh; Anna E Lokshin; Eva Lundin; Paola Muti; Adele Marrangoni; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

4.  Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.

Authors:  Wes Rountree; Nathan Vandergrift; John Bainbridge; Ana M Sanchez; Thomas N Denny
Journal:  J Immunol Methods       Date:  2014-01-20       Impact factor: 2.303

5.  Human norovirus infection and the acute serum cytokine response.

Authors:  K L Newman; C L Moe; A E Kirby; W D Flanders; C A Parkos; J S Leon
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

6.  Effect of periodontal treatment on peak serum levels of inflammatory markers.

Authors:  Adnan Ali Almaghlouth; Norbert Cionca; José Antonio Cancela; Fabien Décaillet; Delphine S Courvoisier; Catherine Giannopoulou; Andrea Mombelli
Journal:  Clin Oral Investig       Date:  2014-01-23       Impact factor: 3.573

7.  A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.

Authors:  Tao Wang; Thomas E Rohan; Marc J Gunter; Xiaonan Xue; Jean Wactawski-Wende; Swapnil N Rajpathak; Mary Cushman; Howard D Strickler; Robert C Kaplan; Sylvia Wassertheil-Smoller; Philipp E Scherer; Gloria Y F Ho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

8.  Effects of serum and plasma matrices on multiplex immunoassays.

Authors:  Yael Rosenberg-Hasson; Leo Hansmann; Michaela Liedtke; Iris Herschmann; Holden T Maecker
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

9.  Metabolic Syndrome, Physical Activity, and Inflammation: A Cross-Sectional Analysis of 110 Circulating Biomarkers in Japanese Adults.

Authors:  Sarah C Van Alsten; Charles S Rabkin; Norie Sawada; Taichi Shimazu; Hadrien Charvat; Taiki Yamaji; Manami Inoue; Troy J Kemp; Ligia A Pinto; M Constanza Camargo; Shoichiro Tsugane; Minkyo Song
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

10.  Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.

Authors:  Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream
Journal:  Cytokine       Date:  2016-12-09       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.